Latest News

Findings point toward one of first therapies for Lou Gehrig's disease

Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Benefits of wellness program for people with multiple sclerosis demonstrated in pilot study

  • Multiple sclerosis drug candidate shows new promise

  • Domestic violence likely more frequent for same-sex couples, review suggests

  • Fear of failure from a young age affects attitude to learning

  • Friend or foe: 'Devastating' number of hate-fuelled crimes are committed by friends, colleagues, carers of victims

  • Narrow focus on physical activity could be ruining kids' playtime

  • Putting dementia carers in control

  • Mechanism of Parkinson's spread demonstrated

  • Nerve cells: Communication without detours

  • Mothers of children with autism less likely to have taken iron supplements in pregnancy, study shows

  •